Some articles from Hematology Times (free membership) on research that may be worth keeping an eye on:
How vitamin D fights lymphoma
Might answer the mystery of why CLL patients with low levels of Vitamin D have a poorer prognosis.
Low doses of imatinib promote hematopoiesis
Perhaps this may prove a way of boosting our immunity if further research and trials are successful.
Imatinib may be better known under its marketing name Gleevec. It's a tyrosine kinase inhibitor that changed Chronic Myeloid Leukaemia (CML) from being a terminal disease into one that could be controlled via maintenance therapy with this drug.
Photo: Peace garden in a nearby town. Today is ANZAC day in Australia and New Zealand (from Australian and New Zealand Army Corps), "a national day of remembrance in Australia and New Zealand that broadly commemorates all Australians and New Zealanders "who served and died in all wars, conflicts, and peacekeeping operations" and "the contribution and suffering of all those who have served." It's the centenary of the landing of ANZAC troops that landed at ANZAC cove 100 years ago today and "who fought at Gallipoli against the Ottoman Empire during World War I. Some Canadian soldiers, who had signed up for service with the United Kingdom, were among the British forces at Gallipoli. In addition, several Canadian military field hospitals supported the campaign."